Your browser doesn't support javascript.
loading
An Integrated Hospital Protocol for Persons With Injection-Related Infections May Increase Medications for Opioid Use Disorder Use but Challenges Remain.
Eaton, Ellen F; Lee, Rachael A; Westfall, Andrew O; Mathews, R E; McCleskey, Brandi; Paddock, Cayce S; Lane, Peter S; Cropsey, Karen L.
Afiliación
  • Eaton EF; Department of Medicine, Division of Infectious Diseases University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Lee RA; Department of Medicine, Division of Infectious Diseases University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Westfall AO; Department of Biostatistics, Ryals School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Mathews RE; Department of Medicine, Division of Hospital Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • McCleskey B; Department of Pathology, Division of Forensics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Paddock CS; Department of Psychiatry, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Lane PS; Department of Psychiatry, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Cropsey KL; Department of Psychiatry, University of Alabama at Birmingham, Birmingham, Alabama, USA.
J Infect Dis ; 222(Suppl 5): S499-S505, 2020 09 02.
Article en En | MEDLINE | ID: mdl-32877555
ABSTRACT

BACKGROUND:

Hospital-based strategies that link persons with infectious complications of opioid use disorder (OUD) to medications for OUD (MOUD) are of great interest. The objective of this study is to determine whether a hospital-based protocol would increase the use of MOUD and to identify barriers to MOUD during admission and at the time of discharge.

METHODS:

This study included participants with a documented or suspected history of injection drug usage receiving care for an infection at the University of Alabama at Birmingham Hospital from 2015 to 2018. The protocol, the intravenous antibiotic and addiction team (IVAT), included Addiction Medicine and Infectious Diseases consultation and a 9-item risk assessment. We quantified MOUD use before and after IVAT and used logistic regression to determine factors associated with MOUD. We explored barriers to MOUD uptake using chart review.

RESULTS:

A total of 37 and 98 patients met criteria in the pre- and post-IVAT periods, respectively. With IVAT, the percentage with OUD receiving MOUD significantly increased (29% pre-IVAT and 37% post-IVAT; P = .026) and MOUD use was higher in "high risk" participants (62%). Clinical and sociodemographic factors were not associated with MOUD receipt.

CONCLUSIONS:

A hospital-based protocol may increase the use of MOUD; however, the uptake of MOUD remains suboptimal (<50%).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Bacterianas / Abuso de Sustancias por Vía Intravenosa / Protocolos Clínicos / Tratamiento de Sustitución de Opiáceos / Trastornos Relacionados con Opioides Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Bacterianas / Abuso de Sustancias por Vía Intravenosa / Protocolos Clínicos / Tratamiento de Sustitución de Opiáceos / Trastornos Relacionados con Opioides Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos